Early-Life Ozone Exposure Linked to Childhood Asthma and Wheeze: JAMA

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-04-27 15:30 GMT   |   Update On 2025-04-27 15:30 GMT
Advertisement

Researchers have found in a new study from JAMA Network Open that exposure to ozone (O₃) early in life is associated with increased risk of asthma and wheeze in young children, especially when combined with other air pollutants. The study, across 6 US cities, shown that children with more exposure to O₃ in their first two years of life had greater odds of asthma and wheeze ages 4-6. These results signal the importance of re-evaluating air quality standards to act for the protection of children from respiratory illness early in life. The study was conducted by Logan C. and fellow researchers.

This was a prospective cohort study that analyzed data from the ECHO-PATHWAYS consortium (2007-2023) utilizing data from 1,188 children from six U.S. cities. Participants were selected if they met the following criteria: had completed airway surveys, were born full-term (gestational age at least 37 weeks) and had full address history from birth to age 2 years.

Researchers evaluated ozone exposure using a spatiotemporal model derived from residential address histories. They employed logistic regression models and Bayesian kernel machine regression (BKMR) analyses to evaluate utter independent and interaction effects of O₃, fine particulate matter (PM₂.₅), and nitrogen dioxide (NO₂) on asthma and wheeze. Adjustments were made for child anthropometric characteristics, family socioeconomic status, and neighborhood factors to account for potential confounding association.

Key Findings

  • Ozone Exposure and AsthmaThe mean (SD) ozone concentration among exposed children was 26.1 (2.9) ppb.

  • Among children aged 4 to 6 years, asthma was reported by 148 (12.3%) children, and wheeze was reported by 190 (15.8%) children.

  • A 2 ppb increase in ozone exposure conferred 31% higher odds of current asthma (OR: 1.31; 95% CI, 1.02-1.68) and 30% higher odds of wheeze (OR: 1.30; 95% CI, 1.05-1.64).

  • At ages 8-9 years, ozone exposure was not substantially associated with asthma or wheeze, suggesting that the effects of early life exposure may be more pronounced with respect to respiratory health in younger children.

  • According to the BKMR analysis, the association between ozone and asthma and wheeze exposure appeared stronger when modeled as part of an air pollution co-mixture that included NO₂ and PM₂.₅.

  • The children had a mean (SD) age of 4.5 (0.6) years at the first airway survey.614 (51.7%) were female, and 663 (55.8%) of mothers had a bachelor’s degree or above.

Early-life exposure to O₃ might cause asthma and wheeze via several mechanisms such as airway inflammation, immune system disruption, interactions with other pollutants, and developmental characteristics.

The study authors concluded that childhood asthma and wheeze risk substantially increased with early-life ozone exposure, particularly among children 4-6 years old. To decrease the prevalent public health burden of childhood asthma, decreasing ambient ozone exposure might be an effective measure for protecting children's respiratory health.

Reference:

Dearborn LC, Hazlehurst MF, Sherris AR, et al. Early-Life Ozone Exposure and Asthma and Wheeze in Children. JAMA Netw Open. 2025;8(4):e254121. doi:10.1001/jamanetworkopen.2025.4121
Tags:    
Article Source : JAMA Network Open

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News